89 related articles for article (PubMed ID: 12706343)
1. Adriamycin activates NF-kappaB in human lung carcinoma cells by IkappaBalpha degradation.
Andriollo M; Favier A; Guiraud P
Arch Biochem Biophys; 2003 May; 413(1):75-82. PubMed ID: 12706343
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
3. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
4. The effect of adenovirus-IkappaBalpha transduction on the chemosensitivity of lung cancer cell line with resistance to cis-diamminedichloroplatinum(II)(cisplatin) and doxorubicin(adriamycin).
Lee CT; Seol JY; Lee SY; Park KH; Han SJ; Yoo CG; Han SK; Shim YS; Kim YW
Lung Cancer; 2003 Aug; 41(2):199-206. PubMed ID: 12871783
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
Boland MP; Fitzgerald KA; O'Neill LA
J Biol Chem; 2000 Aug; 275(33):25231-8. PubMed ID: 10940316
[TBL] [Abstract][Full Text] [Related]
6. [Norcantharidin potentialize the chemosensitivity of adriamycin through the NF-κB/IκBα signaling pathway].
Song XN; Du HF; Yu LJ; Meng YF; Lü HY; Sun LX; Meng JB; Zhang JQ
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):809-13. PubMed ID: 22339951
[TBL] [Abstract][Full Text] [Related]
7. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
[TBL] [Abstract][Full Text] [Related]
8. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
de Jong S; Zijlstra JG; de Vries EG; Mulder NH
Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
[TBL] [Abstract][Full Text] [Related]
9. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection.
Fan S; Gao M; Meng Q; Laterra JJ; Symons MH; Coniglio S; Pestell RG; Goldberg ID; Rosen EM
Oncogene; 2005 Mar; 24(10):1749-66. PubMed ID: 15688034
[TBL] [Abstract][Full Text] [Related]
10. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells.
Chuang SE; Yeh PY; Lu YS; Lai GM; Liao CM; Gao M; Cheng AL
Biochem Pharmacol; 2002 May; 63(9):1709-16. PubMed ID: 12007574
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
13. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
[TBL] [Abstract][Full Text] [Related]
14. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
15. Transfer of IkappaBalpha gene increase the sensitivity of paclitaxel mediated with caspase 3 activation in human lung cancer cell.
Osaki S; Nakanishi Y; Takayama K; Pei XH; Ueno H; Hara N
J Exp Clin Cancer Res; 2003 Mar; 22(1):69-75. PubMed ID: 12725325
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1.
de Groot DJ; van der Deen M; Le TK; Regeling A; de Jong S; de Vries EG
Br J Cancer; 2007 Oct; 97(8):1077-83. PubMed ID: 17940500
[TBL] [Abstract][Full Text] [Related]
17. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
18. Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation.
Yeh PY; Chuang SE; Yeh KH; Song YC; Ea CK; Cheng AL
Biochem Pharmacol; 2002 Apr; 63(8):1423-30. PubMed ID: 11996883
[TBL] [Abstract][Full Text] [Related]
19. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-kappaB activation and reactive oxygen intermediates.
Manna SK; Aggarwal BB
J Immunol; 1999 Feb; 162(3):1510-8. PubMed ID: 9973408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]